Hyperion Defi, Inc.
Pharmaceutical company · Dallas, Texas, United States · Nasdaq: HYPD
Hyperion Defi, Inc. is a pharmaceutical company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker HYPD. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2025.
Hyperion Defi at a glance
What does Hyperion Defi do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $50 million sold (2025).
Frequently asked questions about Hyperion Defi
Where is Hyperion Defi headquartered?
Hyperion Defi, Inc. is headquartered in Dallas, Texas, United States.
What does Hyperion Defi do?
Hyperion Defi, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Hyperion Defi a public company?
Yes. Hyperion Defi, Inc. trades on Nasdaq under the ticker HYPD.
When was Hyperion Defi founded?
The earliest incorporation on record for Hyperion Defi, Inc. is in 2014, according to public company registers.
Similar companies
- Forte Biosciences, Inc.Dallas, Texas, United States
- Lantern Pharma Inc.Dallas, Texas, United States
- CerSci Therapeutics Inc.Dallas, Texas, United States
- Osteal Therapeutics, Inc.Dallas, Texas, United States
- Arog Pharmaceuticals, Inc.Dallas, Texas, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences